Ft. Stewart ACH Malaria Drug Prophylaxis Purchases and Inventory

Dr. Remington Nevin filed this request with the Fort Stewart - Winn Army Community Hospital - MEDDAC of the United States of America.
Tracking #

15-W2MS-00066-F
Submitted Oct. 15, 2014
Status
Completed

Communications

From: Remington Nevin

Subject: None

Email

To Whom It May Concern:

This is a request under the Freedom of Information Act. I hereby request the following records:

Any and all available purchase or acquisition records since September 1, 2014, and the most recently available inventory records, from the Ft. Stewart Army Community Hospital pharmacy to include any satellite pharmacies, listing quantities of atovaquone-proguanil (Malarone), mefloquine, and doxycycline purchased or on hand, to specifically include any purchases or acquisitions made in anticipation of dispensing to personnel of the 82nd Civil Affairs Battalion deploying to Africa as part of Operation United Assistance or any other U.S. military missions in response to the 2014 west African Ebola outbreak.

I also request that, if appropriate, fees be waived as I believe this request is in the public interest. The requested documents will be made available to the general public free of charge as part of the public information service at MuckRock.com, processed by a representative of the news media/press and is made in the process of news gathering and not for commercial usage.

In the event that fees cannot be waived, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.

Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.

Sincerely,

Remington Nevin

From: Cross, Ricky E CIV USARMY MEDCOM WINN (US)

Subject: None

Email

Classification: UNCLASSIFIED
Caveats: NONE

Dear Mr Nevin:

Attached is FOIA Acknowledgement Letter.

Ricky E. Cross
Privacy Officer
(912) 435-6507
DSN 475-6507 Fax (912) 435-5255
"CONFIDENTIALITY NOTICE" This document may contain information covered
under the Privacy Act, 5 USC 552(a), and/or the Health Insurance Portability
and Accountability Act (PL 104-191) and its various implementing regulations
and must be protected in accordance with those provisions. Healthcare
information is personal and sensitive and must be treated accordingly. If
this correspondence contains healthcare information it is being provided to
you after appropriate authorization from the patient or under circumstances
that don't require patient authorization. You, the recipient, are obligated
to maintain it in a safe, secure and confidential manner. Re-disclosure
without additional patient consent or as permitted by law is prohibited.
Unauthorized
re-disclosure or failure to maintain confidentiality subjects you to
application of appropriate sanction. If you have received this
correspondence in error, please notify the sender at once and destroy any
copies you have made.

Classification: UNCLASSIFIED
Caveats: NONE

From: Cross, Ricky E CIV USARMY MEDCOM WINN (US)

Subject: None

Email

Classification: UNCLASSIFIED
Caveats: NONE

Mr. Nevin:

Attached is the response on your FOIA request.

Ricky E. Cross
Privacy Officer
(912) 435-6507
DSN 475-6507 Fax (912) 435-5255
"CONFIDENTIALITY NOTICE" This document may contain information covered
under the Privacy Act, 5 USC 552(a), and/or the Health Insurance Portability
and Accountability Act (PL 104-191) and its various implementing regulations
and must be protected in accordance with those provisions. Healthcare
information is personal and sensitive and must be treated accordingly. If
this correspondence contains healthcare information it is being provided to
you after appropriate authorization from the patient or under circumstances
that don't require patient authorization. You, the recipient, are obligated
to maintain it in a safe, secure and confidential manner. Re-disclosure
without additional patient consent or as permitted by law is prohibited.
Unauthorized
re-disclosure or failure to maintain confidentiality subjects you to
application of appropriate sanction. If you have received this
correspondence in error, please notify the sender at once and destroy any
copies you have made.

Classification: UNCLASSIFIED
Caveats: NONE

Files

pages

 Close